Project Aura: Co-design

  • Research type

    Research Study

  • Full title

    Project Aura: Co-design of a home monitoring solution for patients with anaemia of chronic kidney disease, carers and healthcare professionals to optimise delivery of treatment

  • IRAS ID

    271364

  • Contact name

    Richard Bodington

  • Contact email

    r.bodington@nhs.net

  • Sponsor organisation

    Entia Ltd

  • Clinicaltrials.gov Identifier

    NCT04112615

  • Duration of Study in the UK

    0 years, 12 months, 0 days

  • Research summary

    The study is sponsored by Entia and funded by Innovate UK. This project is a co-design initiative between the investigator team, patients, carers, and health professionals at Hull University Teaching Hospitals NHS Trust.

    Entia, in partnership with Hull University Teaching Hospitals NHS Trust will develop a patient monitoring solution to optimise delivery of specialist care for patients with anaemia of chronic kidney disease (CKD). This patient cohort are of interest as they have to have regular (usually monthly) blood tests done to monitor their condition and prescribe treatment. As a part of this service, a haematological analyser and associated phone application will be co-designed. It will be capable of performing a haemoglobin and haematocrit measurement from a small amount of blood. We hope through this technology to improve the experience of receiving treatment for patients and their carers whilst helping healthcare professionals to plan and manage the care of patients, in particular, those undergoing ESA therapy.

    In order to ensure a user-friendly design that meets end user needs, we propose to develop the solution using a co-design model. Patients and carers, along with healthcare professionals and innovators, are all partners in this design process. The co-design process will cover the development of the device, the test and any supporting technology (mobile application) or material if necessary. Participants will be directly involved in bringing a fully functional, innovative service to the market that will improve patients quality of life and aid healthcare professionals when managing anaemia. Entia has led co-design studies previously and will have an active input in the workshops.

  • REC name

    London - Brent Research Ethics Committee

  • REC reference

    19/LO/1883

  • Date of REC Opinion

    28 Jan 2020

  • REC opinion

    Further Information Favourable Opinion